Merck started its Acceleron pursuit at $160 per share, but CEO Davis balked at paying more than $180
Merck started its Acceleron pursuit at $160 per share, but [...]
Spinoff or $54B sale? GlaxoSmithKline’s consumer health outfit draws buyout interest: report
Spinoff or $54B sale? GlaxoSmithKline’s consumer health outfit draws buyout [...]
Viatris to close former Novartis site in California in January, lay off 75
Viatris to close former Novartis site in California in January, [...]
Supernus strikes $400M+ Adamas buyout as its top drug heads toward the patent cliff
Supernus strikes $400M+ Adamas buyout as its top drug heads [...]
Pacira boosts nonopioid pain portfolio via $450M Flexion buy, with more CVR payments to come
Pacira boosts nonopioid pain portfolio via $450M Flexion buy, with [...]
Samsung Biologics speeds $2B plant build forecast to boost capacity 70%
Samsung Biologics speeds $2B plant build forecast to boost capacity [...]
ChemoCentryx scores first FDA approval in 24-year history, and CEO Schall sees a blockbuster in the making
ChemoCentryx scores first FDA approval in 24-year history, and CEO [...]
Sanofi, GSK, Pfizer and Boehringer must face Zantac class-action lawsuits, court rules
Sanofi, GSK, Pfizer and Boehringer must face Zantac class-action lawsuits, [...]
Amgen’s latest Lumakras data in KRAS cancer underscore the bumpy road for combo strategy: analyst
Amgen’s latest Lumakras data in KRAS cancer underscore the bumpy [...]
Neurocrine raises a new monument to mental health in pandemic resilience campaign
Neurocrine raises a new monument to mental health in pandemic [...]